Shigehiro Katayama Selected Research

Shigehiro Katayama Research Topics

Disease

23	Type 2 Diabetes Mellitus (MODY) 11/2017 - 05/2002
10	Hypertension (High Blood Pressure) 01/2018 - 04/2002
10	Insulin Resistance 01/2012 - 05/2003
6	Diabetic Nephropathies (Diabetic Nephropathy) 01/2018 - 01/2002
6	Diabetes Mellitus 06/2009 - 01/2003
5	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2015 - 05/2002
5	Atherosclerosis 01/2009 - 01/2003
4	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 03/2018 - 02/2002
4	Hyperglycemia 11/2017 - 07/2006
4	Albuminuria 04/2017 - 02/2006
4	Body Weight (Weight, Body) 09/2015 - 07/2002
4	Coronary Disease (Coronary Heart Disease) 05/2012 - 02/2010
4	Dyslipidemias (Dyslipidemia) 02/2011 - 08/2009
4	Metabolic Syndrome (Dysmetabolic Syndrome X) 02/2010 - 10/2005
3	Diabetes Complications 02/2017 - 11/2011
3	Obesity 01/2012 - 04/2005
3	Macular Degeneration (Age-Related Maculopathy) 06/2011 - 11/2007
3	Cardiovascular Diseases (Cardiovascular Disease) 03/2009 - 10/2005
3	Graves Disease (Basedow Disease) 01/2009 - 08/2002
3	Thyroiditis 01/2009 - 04/2003
3	Glucose Intolerance 10/2008 - 07/2006
2	Abdominal Obesity 03/2009 - 10/2005
2	Hypertrophy 01/2007 - 01/2005
2	Proteinuria 02/2006 - 01/2005
2	Macular Edema 08/2005 - 09/2004
2	Hyperplasia 04/2005 - 04/2002
2	Neointima 02/2004 - 02/2003
1	Hepatitis B 07/2019
1	Adrenal Insufficiency (Adrenal Gland Hypofunction) 07/2019
1	Rheumatic Diseases (Rheumatism) 07/2019
1	Hyperkalemia 04/2017
1	Adrenocortical Carcinoma 01/2016
1	Hypersensitivity (Allergy) 01/2015
1	Stroke (Strokes) 10/2014
1	Weight Gain 07/2014

Drug/Important Bio-Agent (IBA)

8	Glucose (Dextrose)FDA LinkGeneric 01/2018 - 12/2004
7	Insulin (Novolin)FDA Link 05/2015 - 06/2004
7	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 11/2011 - 02/2002
6	Pharmaceutical PreparationsIBA 11/2017 - 07/2006
6	Angiotensin Receptor AntagonistsIBA 04/2012 - 02/2006
5	LipidsIBA 05/2012 - 07/2003
5	oxidized low density lipoproteinIBA 06/2010 - 07/2006
4	olmesartanIBA 10/2015 - 03/2011
4	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 10/2015 - 06/2004
4	Triglycerides (Triacylglycerol)IBA 11/2011 - 07/2006
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2011 - 05/2002
4	AdiponectinIBA 01/2010 - 12/2004
3	Dipeptidyl-Peptidase IV InhibitorsIBA 01/2018 - 10/2014
3	Hypoglycemic Agents (Hypoglycemics)IBA 11/2017 - 06/2004
3	Sitagliptin Phosphate (Januvia)FDA Link 03/2016 - 10/2014
3	AlbuminsIBA 05/2013 - 01/2005
3	HDL CholesterolIBA 05/2013 - 08/2009
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 06/2010 - 03/2004
3	LDL Lipoproteins (beta Lipoproteins)IBA 02/2010 - 07/2006
3	PPAR gammaIBA 01/2010 - 12/2004
3	Telmisartan (Micardis)FDA Link 01/2010 - 06/2007
3	Acarbose FDA LinkGeneric 05/2009 - 07/2006
3	glimepiride (Amarel)FDA LinkGeneric 03/2009 - 03/2005
3	Proteins (Proteins, Gene)FDA Link 01/2009 - 04/2005
3	Nitric Oxide (Nitrogen Monoxide)FDA Link 09/2004 - 02/2004
2	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 11/2017 - 03/2004
2	mitiglinideIBA 03/2016 - 03/2009
2	DiureticsIBA 10/2015 - 10/2014
2	AntioxidantsIBA 01/2015 - 10/2012
2	Untranslated RNA (Noncoding RNA)IBA 01/2015 - 01/2014
2	Alkaline PhosphataseIBA 07/2013 - 05/2007
2	CreatinineIBA 05/2013 - 06/2007
2	EnzymesIBA 10/2012 - 07/2002
2	Antihypertensive Agents (Antihypertensives)IBA 04/2012 - 08/2009
2	LDL CholesterolIBA 11/2011 - 06/2010
2	Fatty Acids (Saturated Fatty Acids)IBA 06/2011 - 07/2006
2	Complement Factor H (Factor H)IBA 01/2011 - 11/2007
2	pigment epithelium-derived factorIBA 01/2011 - 09/2007
2	Lipoproteins (Lipoprotein)IBA 02/2010 - 01/2009
2	AMP-Activated Protein KinasesIBA 11/2008 - 03/2005
2	imidaprilIBA 07/2006 - 02/2002
2	Biomarkers (Surrogate Marker)IBA 07/2006 - 01/2006
2	CalciumIBA 04/2005 - 03/2004
2	Collagen Type IV (Type IV Collagen)IBA 01/2005 - 01/2002
2	Fibric Acids (Fibrates)IBA 06/2004 - 03/2004
2	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 01/2004 - 08/2002
1	Immunosuppressive Agents (Immunosuppressants)IBA 07/2019
1	Adrenal Cortex Hormones (Corticosteroids)IBA 07/2019
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 07/2019
1	Programmed Cell Death 1 ReceptorIBA 03/2018
1	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2018
1	Glucagon-Like Peptide-1 Receptor AgonistsIBA 01/2018
1	PotassiumIBA 04/2017
1	finerenoneIBA 04/2017
1	Hemoglobins (Hemoglobin)IBA 02/2017
1	Liraglutide FDA Link 09/2015
1	Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA 05/2015
1	VildagliptinIBA 05/2015
1	Dipeptidyl-Peptidases and Tripeptidyl-PeptidasesIBA 10/2014
1	Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA 07/2014
1	Anti-Bacterial Agents (Antibiotics)IBA 12/2013

Therapy/Procedure

6	Therapeutics 07/2019 - 10/2005
6	Glycemic Control 10/2014 - 11/2002
1	Drug Therapy (Chemotherapy) 11/2017
1	Adrenalectomy 01/2016